Dr. Kadera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1304 15th St
Ste 102
Santa Monica, CA 90404Phone+1 310-393-3583Fax+1 310-394-5215
Summary
- My clinical practice includes general surgical oncology, with an emphasis in soft tissue sarcoma and gastric malignancies, including minimally invasive and robotically-assisted techniques. My research is focused on the development of targeted therapy and neoadjuvant clinical trials for soft tissue sarcoma.
Clinical Expertise
- Gastrointestinal stromal tumors, Gastric cancer, Surgical oncology (non-breast), Soft tissue sarcomas, Robotic surgery, Cholangiocarcinoma
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2016 - 2018
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2009 - 2016
- Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, 2011 - 2013
- Duke University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - 2026
- NY State Medical License 2016 - 2019
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Associate Fellow American College of Surgeons
- Gerald S. Levey Research Scholarship UCLA Department of Surgery, 2011-2013
- Department of Surgery Chairman Scholarship Duke University School of Medicine, 2007-2009
Publications & Presentations
PubMed
- CT Imaging as a Single Modality for Clinical Staging of Gastric Cancer in Limited Resource Centers: A Retrospective Pilot Study.Kyle D Klingbeil, Isabel K Eng, Priyanka Dube, Dustin L Dillon, Kirollos Bechay
Journal of Surgical Oncology. 2024-10-15 - Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma.Kyle D Klingbeil, Blake R Wilde, Danielle S Graham, Serena Lofftus, Tyler McCaw
Cancers. 2024-08-30 - 2 citationsIGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.Kyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, Serena Y Lofftus, Amit Kumar Jaiswal
Cancers. 2023-09-09
Authored Content
- Colorectal Liver Metastasis11/15/2018
- Palliative Therapy for Pancreatic Cancer12/12/2016
Press Mentions
- Prolonged Pre-Op Chemo Improved Survival in Pancreatic CancerDecember 13th, 2013
- #ASC2024: Ethnicity as Survival Predictor for Gastric Cancer, Early Liver Retransplantation, Risk Factors for Chemical Restraint Use Among Adult Trauma Patients and MoreJanuary 26th, 2024
Grant Support
- Influence of SRC Signaling on Human Pancreatic Cancer Progression and Stem Cell TransformationCalifornia Institute of Regenerative Medicine2011–2013
Committees
- Chief Administrator, Morbidity & Mortality Conference, UCLA Surgical Quality Improvement Committee 2015 - 2016
- Founding Member, UCLA Trauma Quality Improvement Committee 2015 - 2016
Professional Memberships
- Member
- Member
- Member
- Member
External Links
- UCLA Homepagehttp://uclahealth.org/brian-kadera
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: